PEPTIDE NOVA

MAZDUTIDE 10MG

Original price was: $189.99.Current price is: $158.99.

Sale!

Description

Product Overview

Mazdutide is a synthetic peptide referenced in scientific literature and studied in peptide research involving endocrine signaling, cell signaling pathways, and molecular regulatory mechanisms. Within controlled laboratory and preclinical research environments, this peptide is examined as a laboratory peptide compound for its amino acid sequence, structural properties, and interaction with experimental molecular and cellular systems.

As a synthetic peptide compound, Mazdutide is utilized in experimental studies to investigate peptide molecular structure, peptide signaling pathways, and laboratory peptide characterization, providing insight into intracellular signaling dynamics and molecular regulation.

Mazdutide is a synthetic signaling peptide analog studied in laboratory research for its potential interactions with cellular signaling pathways, receptor-mediated molecular mechanisms, and intracellular regulatory networks.

Researchers examine Mazdutide to study peptide sequence behavior, receptor-mediated signaling interactions, and molecular signaling pathways. Its amino acid sequence and structural design are analyzed in laboratory and preclinical research models to better understand peptide signaling dynamics, molecular regulation, and intracellular peptide-mediated communication.

Experimental studies involving Mazdutide include:

  • peptide signaling pathways

  • cell signaling research

  • receptor binding interactions

  • molecular signaling mechanisms

  • endocrine signaling peptide activity

  • peptide stability and structural activity

  • laboratory peptide characterization

  • intracellular signaling cascade analysis

  • metabolic and regulatory pathway research

All studies are conducted strictly in controlled laboratory and preclinical research environments.

Compound Name: Mazdutide
Peptide Classification: Synthetic signaling peptide analog
Molecular Formula: Referenced in scientific literature
Molecular Weight: Referenced in literature (approximate, based on analog design)
Amino Acid Sequence: Referenced in scientific literature
CAS Number: Referenced in scientific literature

Mazdutide is a synthetic peptide analog designed for laboratory investigation of peptide signaling pathways, molecular regulatory mechanisms, and receptor-mediated intracellular communication. Researchers study its peptide molecular structure and sequence using techniques such as chromatography, mass spectrometry, and laboratory peptide characterization to assess structural integrity, sequence stability, and signaling potential.

Scientific literature has examined Mazdutide in experimental and preclinical studies investigating peptide signaling pathways, receptor-mediated molecular interactions, and intracellular regulatory networks.

In research models, this peptide has been studied in relation to cellular signaling cascades, receptor-mediated molecular interactions, and molecular regulatory mechanisms. All investigations are conducted strictly in controlled laboratory or preclinical research environments, focusing solely on the scientific characterization of this synthetic peptide compound.

Compound Name: Mazdutide
Peptide Classification: Synthetic signaling peptide analog
Format: Lyophilized Powder
Quantity: 10MG
Research Category: Peptide research / molecular signaling research / laboratory peptide characterization
Storage Recommendations: Store refrigerated in a cool, dry environment protected from light and moisture. Long-term storage under controlled laboratory refrigeration is recommended.

Research Use Only. Not for human or veterinary use. Not approved by the FDA and not intended to diagnose, treat, cure, or prevent any disease.

Links To Research Studies

Links to Studies:

Mazdutide demonstrated robust HbA1c reduction and significant weight loss in Chinese patients with type 2 diabetes in a Phase 2 randomized controlled trial, confirming both glycemic and metabolic benefits

A 24-week Phase 2 trial of Mazdutide up to 6 mg in overweight and obese adults showed dose-dependent weight loss up to 11% and strong safety, marking it as a leading dual GLP‑1/glucagon receptor agonist candidate

Phase 3 DREAMS‑2 study results revealed Mazdutide’s superiority over dulaglutide in glycemic control, weight reduction, and cardiometabolic improvements in Chinese patients with type 2 diabetes

China’s NMPA approved Mazdutide, the first dual GLP‑1/glucagon receptor agonist for chronic weight management, offering dual fat‑burning and metabolic enhancement benefits

ADA 2024 abstract: Mazdutide significantly reduced body weight and liver steatosis while improving cardiometabolic parameters in overweight and obese patients

ADA 2024 abstract: Mazdutide demonstrated marked efficacy and safety in obese and overweight Chinese adults, achieving meaningful metabolic and hepatic benefits

Recent meta‑analysis confirmed Mazdutide’s dual‑agonist mechanism significantly improves glucose regulation and induces superior body‑weight reductions compared with other GLP‑1 therapies

Extended Phase 3 and metabolic trials of Mazdutide continue to highlight its potential as a first‑in‑class dual incretin therapy for obesity and diabetes management worldwide

AS SEEN ON

Infinite Logo Marquee
logo1 logo2 logo3 logo4 logo1-duplicate logo2-duplicate logo3-duplicate logo4-duplicate

Legal Disclaimer

For research purposes only. Not for consumption, clinical use, or diagnostic purposes. Buyer assumes all responsibility for proper handling and use in compliance with applicable regulations.

Satisfaction Guaranteed

30-Day Replacement Policy

Customer Service

Chat, Phone & E-Mail

Fast Shipping

Priority Shipping

Quality Tested

Third-Party Tested

You May Also Like